Maximus (NYSE:MMS) Reaches New 12-Month Low – Here’s Why

Maximus, Inc. (NYSE:MMSGet Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $56.92 and last traded at $59.4150, with a volume of 45899 shares traded. The stock had previously closed at $59.90.

Analysts Set New Price Targets

A number of brokerages recently commented on MMS. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Weiss Ratings cut shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, Maximus currently has an average rating of “Hold”.

View Our Latest Analysis on Maximus

Maximus Stock Performance

The firm has a market cap of $3.16 billion, a P/E ratio of 8.96 and a beta of 0.60. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The business’s fifty day simple moving average is $66.33 and its 200-day simple moving average is $78.53.

Maximus (NYSE:MMSGet Free Report) last announced its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.09. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a net margin of 7.02% and a return on equity of 25.10%. The company’s revenue was down 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.01 EPS. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. As a group, sell-side analysts expect that Maximus, Inc. will post 8.4 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, May 15th. Maximus’s dividend payout ratio (DPR) is 19.76%.

Insider Transactions at Maximus

In other Maximus news, Director Jan Madsen sold 742 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This trade represents a 3.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Maximus

A number of large investors have recently modified their holdings of MMS. Richardson Financial Services Inc. grew its stake in shares of Maximus by 29.6% in the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after acquiring an additional 103 shares during the period. Farther Finance Advisors LLC grew its stake in shares of Maximus by 69.0% in the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after acquiring an additional 116 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Maximus by 13.4% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,268 shares of the health services provider’s stock worth $109,000 after acquiring an additional 150 shares during the period. Arizona State Retirement System grew its stake in shares of Maximus by 0.9% in the third quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock worth $1,524,000 after acquiring an additional 156 shares during the period. Finally, Blue Trust Inc. grew its stake in shares of Maximus by 14.6% in the first quarter. Blue Trust Inc. now owns 1,321 shares of the health services provider’s stock worth $85,000 after acquiring an additional 168 shares during the period. Institutional investors own 97.21% of the company’s stock.

About Maximus

(Get Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Read More

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.